Cardiac transplantation for hypoplastic left heart syndrome

Cardiology in the Young
R J Boucek, M R K Chrisant

Abstract

Future improvements can be expected in cardiac transplantation in children. We continue to advance our understanding of the immune system, and to develop more specific immunosuppressive agents. Ultimately, the future for recipients may be improved by strategies such as induction therapy or donor-derived chimeric destined transfusions, designed to enhance the tolerance of the host to a human leukocyte antigen incompatible graft. Improvements in tolerance of the host would allow for reduction or elimination of many, if not all, of the immunosuppressive agents, and for longevity extending well into the adulthood. Survival, particularly for infants, has improved dramatically in the last decade. The most recent results from the registry of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing show that recipients less than one year old at transplantation, who survive the first year, have greater than a 95% survival to four years (Fig. 1). As late outcomes continue to improve, transplantation will provide a better quality and duration of life for infants with hypoplastic left heart syndrome. It is possible, nonetheless, that some infants will require retransplantation, since the half life of a t...Continue Reading

References

Oct 9, 1986·The New England Journal of Medicine·L L BaileyE L Petry
Mar 1, 1996·The Annals of Thoracic Surgery·C C EkeL L Bailey
Jul 1, 1996·The Annals of Thoracic Surgery·K BandoJ W Brown
Sep 1, 1996·Brain, Behavior, and Immunity·A KavelaarsC J Heunen
Mar 20, 1998·Pediatric Research·R L SchelonkaA J Infante
Apr 2, 1998·Seminars in Perinatology·R L Schelonka, A J Infante
May 30, 1998·The Journal of Thoracic and Cardiovascular Surgery·W J WellsM Barr
Mar 31, 1999·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·E L Bove
Jun 11, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·R J BoucekS DiSano
Dec 22, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D G RenlundR S Shaddy
May 16, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·H C LeonardJ H Dark
Sep 1, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D N RosenthalD Bernstein
Oct 12, 2000·Journal of the American College of Cardiology·P C JenkinsG T O'Connor
Feb 13, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·M M BoucekJ D Hosenpud
Mar 15, 2001·The New England Journal of Medicine·L J WestJ G Coles
Mar 21, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·E PahlUNKNOWN Pediatric Heart Transplant Study
Aug 15, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·T Wekerle
Mar 19, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jill E IbrahimCharles E Canter
Jul 13, 2004·Cardiology in the Young·Leonard L Bailey
Sep 3, 2004·The Journal of Pediatrics·Marti BaumLeonard Bailey

❮ Previous
Next ❯

Citations

Jun 7, 2005·Expert Opinion on Pharmacotherapy·Eric M GrahamAndrew M Atz
Mar 28, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jeffrey D DaytonWilliam T Mahle
Feb 9, 2010·Congenital Heart Disease·Kimberly E McHughHoward P Gutgesell
Jan 4, 2007·Pediatrics·Bahaaldin AlsoufiChristopher A Caldarone
Jan 4, 2012·Journal of the American College of Cardiology·Jeffrey A FeinsteinGerard R Martin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
M R K ChrisantPediatric Heart Transplant Study Group
The New England Journal of Medicine
L J WestJ G Coles
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Richard KirkMarshall I Hertz
© 2022 Meta ULC. All rights reserved